Loading... Please wait...

Categories

Our Newsletter


CX-5461 | RNA Pol I inhibitor

  • CX-5461.jpg
  • CX-5461, 400x400px, png
Price:
$159.00
Catalog #:
C2954-2s
Quantity:


Product Description

CX-5461 is a potent, orally bioavailable small molecule inhibitor of rRNA synthesis in cancer cells. It selectively inhibits rRNA synthesis by polymerase I (Pol I) in the nucleolus, but does not inhibit mRNA synthesis by RNA Polymerase II (Pol II), DNA replication or protein synthesis. (In tested cell lines, IC50s for Pol I range from 54nmol/L to 142nmol/L, IC50s for Pol II is higher than 25umol/L.)

CX-5461 exhibits a broad range of antiproliferative activity, with wild-type (wt) p53 cells derived from hematological malignancies being the most sensitive. (p53 wt solid tumors: median IC50=164 nM; p53 wt hematologic cancers cells: median IC50=25 nM). CX-5461 selectively kills cancer cells relative to normal cells. (Median IC50 in normal cells is 5,000 nM.) CX-5461 directly targets the initiation stage of rRNA synthesis, induces both autophagy and senescene, but not apoptosis in a p53-independent process in solid tumor cell lines. In wt p53 hematologic cancer cells, however, inhibition of Pol I results in nucleolar stress and release of ribosomal proteins (RP) from the nucleolus. The RP bind to Mdm2 and release p53 to cause apoptosis in cancer cells. CX-5461 exhibits potent in vivo antitumor activity against both human solid tumor in xenograft models, and leukemia and lymphoma in animal models [1-2].


Technical information:

Chemical Formula:   C27H27N7O2S
CAS #:   1138549-36-6
Molecular Weight:   513.61
Purity:   > 98%
Appearance:   White
Chemical Name:   5H-Benzothiazolo[3,2-a][1,8]naphthyridine-6-carboxamide, 2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-N-[(5-methyl-2-pyrazinyl)methyl]-5-oxo-
Solubility:   Up to 1 mM in DMSO
Synonyms:   CX-5461, CX5461

Shipping Condition: The product is shipped in a glass vial at ambient temperature.
Storage condition: For longer shelf life, store solid powder at 4oC desiccated, or store DMSO solution at -20oC.


Reference:

1. Drygin D., et al. Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth. Cancer Res. 2011. 71(4):1418-30. Pubmed ID: 21159662
2. Bywater MJ., et al. Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53. Cancer Cell. 2012. 22(1):51-65. Pubmed ID: 22789538

Other Information:

Product Specification (pdf)
MSDS (pdf)
Certificate of Analysis is available upon request.

Write your own product review

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product!

Add to Wish List

Click the button below to add the CX-5461 | RNA Pol I inhibitor to your wish list.

You Recently Viewed...